Here To Help Clients To A Better Future

The Grants Game: How Research Funding Dependency Enables Harassment in Clinical Trials

by | Jul 2, 2026 | Firm News

Scientific research is often portrayed as an objective pursuit driven by data, innovation, and collaboration. Behind many medical breakthroughs, however, lies a highly competitive funding system in which researchers depend on grants, principal investigators, and institutional support to sustain their careers. For many professionals working in clinical research, continued employment, future promotions, and publication opportunities are closely tied to obtaining and maintaining research funding.
While grant funding is essential to advancing medicine and science, it can also create significant power imbalances within research institutions. Graduate students, research coordinators, laboratory staff, postdoctoral fellows, and junior investigators frequently rely on a single principal investigator or department chair for funding, mentorship, recommendations, and continued employment. When that authority is abused, workers may feel that reporting misconduct could jeopardize not only their current position but their entire research career.
Allegations involving sexual harassment in academic medicine and clinical research have demonstrated that harassment often persists because victims fear losing access to grant-funded positions, research opportunities, and professional networks. In some situations, employees describe feeling trapped between protecting their careers and protecting themselves from inappropriate conduct.
Employment laws prohibit workplace harassment regardless of the industry, including universities, hospitals, pharmaceutical companies, nonprofit research organizations, and private research institutions. Understanding how funding structures influence workplace dynamics is important because the legal analysis focuses not only on individual acts of harassment but also on whether employers created environments that allowed misconduct to continue.
I. Grant Funding and the Power Structure in Clinical Research
Modern clinical research depends heavily on external funding. Universities, teaching hospitals, and research organizations compete for grants from federal agencies, nonprofit organizations, and private industry sponsors. These grants often support salaries, laboratory expenses, equipment purchases, and the personnel required to conduct clinical trials.
Because research funding is finite, many investigators spend substantial portions of their careers applying for grants and maintaining financial support for their projects. Junior researchers frequently join laboratories whose funding is controlled almost entirely by a principal investigator. That principal investigator may determine hiring decisions, work assignments, publication opportunities, conference attendance, and recommendations for future positions.
This concentration of authority creates a workplace unlike many traditional employment settings. A research assistant or clinical coordinator may technically be employed by a university or hospital, yet their day-to-day responsibilities and career progression are often controlled by a single supervisor whose grant funds support the position.
The resulting imbalance can become significant when workplace misconduct occurs.
An employee experiencing sexual harassment may fear that reporting the conduct will lead to removal from a research project, exclusion from publications, negative performance evaluations, or the loss of funding supporting their position. In academic medicine, where professional advancement depends heavily on publications, references, and successful collaborations, these consequences may have long-term career implications.
Grant dependency can also discourage witnesses from coming forward. Laboratory personnel may worry that reporting misconduct could disrupt funding, delay important research, or jeopardize the employment of everyone working on the project. As a result, individuals who observe inappropriate behavior may remain silent despite recognizing that the conduct is unacceptable.
None of these structural characteristics excuse workplace misconduct. Instead, they illustrate why institutions overseeing clinical research should implement robust reporting systems, independent investigations, and safeguards that reduce the influence any one individual has over another employee’s career.
II. Sexual Harassment in Research Settings and Employer Responsibility
Federal and state employment laws apply fully to research institutions. Universities, hospitals, pharmaceutical companies, contract research organizations, and nonprofit research centers all have legal obligations to provide workplaces free from unlawful harassment and discrimination.
Workplace sexual harassment generally falls into two categories: quid pro quo harassment and hostile work environment harassment.
Quid pro quo harassment occurs when employment opportunities or professional benefits are conditioned upon submission to unwelcome sexual conduct. Within clinical research, this might involve suggestions that continued grant funding, authorship on publications, conference travel, promotions, or future recommendations depend upon accepting inappropriate advances.
Hostile work environment claims arise when unwelcome conduct becomes sufficiently severe or pervasive to alter the conditions of employment. Courts evaluate the totality of the circumstances, considering factors such as the frequency of the conduct, its severity, whether it involved physical threats or humiliation, and whether it interfered with an employee’s ability to perform their work.
Research environments can present unique factual circumstances during these analyses. Laboratories often involve relatively small teams working closely together for months or years. Clinical trial staff may travel together, attend conferences, conduct patient visits, or spend extended hours completing regulatory requirements under demanding deadlines. These professional settings may blur workplace boundaries if appropriate safeguards are not maintained.
Power dynamics also play an important role. Principal investigators frequently exercise significant influence over publication decisions, authorship credit, letters of recommendation, fellowship opportunities, and grant-supported employment. Because these decisions directly affect future career prospects, inappropriate conduct from supervisors may carry particularly coercive effects.
Employer responsibility extends beyond responding to individual complaints. Research institutions should establish reporting mechanisms that allow employees to bypass supervisors accused of misconduct. Independent human resources departments, ombudsperson offices, compliance hotlines, and Title IX coordinators at educational institutions may all serve important roles in ensuring complaints receive impartial review.
Failure to investigate allegations thoroughly may increase legal exposure, particularly when evidence suggests prior complaints involving the same supervisor. Plaintiffs sometimes argue that institutions ignored warning signs because successful investigators generated substantial grant revenue or enhanced institutional prestige.
These cases illustrate an important legal principle: research productivity does not excuse unlawful workplace conduct. Institutions cannot prioritize grant income over employee safety and compliance with anti-discrimination laws.
III. Protecting Employees Working in Grant-Funded Research
Employees experiencing harassment in clinical research often hesitate to report concerns because they fear damaging professional relationships or losing funding opportunities. While these concerns are understandable, documenting misconduct and understanding available legal protections can be critical.
Documentation frequently plays an important role in workplace investigations and litigation. Employees should consider maintaining contemporaneous records describing incidents, including dates, locations, individuals present, and the specific conduct that occurred. Notes created shortly after events take place may later help establish timelines and corroborate testimony.
Electronic communications should also be preserved whenever possible. Emails, text messages, messaging platform communications, calendar invitations, and other records may become important evidence if allegations are disputed. Because research work increasingly relies on digital collaboration, electronic communications often provide valuable context regarding workplace interactions.
Witnesses may likewise strengthen harassment claims. Colleagues who observed inappropriate comments, differential treatment, or changes in workplace behavior may later provide important testimony. Even individuals who did not directly witness misconduct may confirm surrounding circumstances or patterns of behavior.
Employees should become familiar with their institution’s reporting procedures. Universities and medical centers often maintain multiple reporting channels beyond an immediate supervisor. Human resources departments, compliance offices, ethics hotlines, Title IX offices, and designated research integrity officials may all receive workplace complaints depending on the circumstances.
Some employees worry that reporting misconduct will inevitably result in retaliation. Federal and state laws generally prohibit employers from retaliating against workers who make good-faith complaints regarding unlawful harassment or participate in workplace investigations. Retaliation may include termination, demotion, reduced responsibilities, exclusion from research opportunities, negative evaluations, or other adverse employment actions connected to protected activity.
Recognizing retaliation can be particularly important in grant-funded environments. Removal from a research project, denial of authorship, exclusion from conference presentations, or abrupt changes to funding assignments may raise legal concerns if they occur because an employee reported harassment rather than for legitimate performance reasons.
Consulting an employment attorney early in the process can help employees evaluate potential claims, preserve evidence, identify applicable filing deadlines, and understand interactions between institutional investigations and potential legal proceedings.
Importantly, workers should remember that professional ambition and personal safety are not mutually exclusive. No employee should be forced to choose between advancing scientific research and working in an environment free from unlawful harassment.
Conclusion
The success of modern clinical research depends upon collaboration, innovation, and trust. Yet the same funding structures that make groundbreaking research possible can also create significant power imbalances between supervisors and junior researchers.
When continued employment, publication opportunities, professional recommendations, and grant-supported salaries depend upon a single decision-maker, employees may feel enormous pressure to tolerate inappropriate conduct rather than risk their careers. This grant funding harassment dependency can discourage reporting, isolate victims, and allow misconduct to persist within research institutions.
Employment laws recognize these realities. Universities, hospitals, pharmaceutical companies, and research organizations have a legal responsibility to prevent workplace sexual harassment, investigate complaints promptly, and protect employees from retaliation. Scientific achievement and successful grant acquisition do not diminish these obligations.
For employees experiencing harassment, early documentation, preservation of communications, and understanding institutional reporting options can play important roles in protecting legal rights. Seeking legal guidance may also help workers navigate complex situations involving grant funding, employment status, and potential retaliation.
Scientific progress depends on the integrity of the people conducting the research as much as the research itself. Maintaining workplaces that are safe, respectful, and free from unlawful harassment protects not only individual employees but also the credibility of the institutions responsible for advancing medicine and improving public health. When research organizations address misconduct appropriately, they strengthen both workplace culture and the scientific mission they are entrusted to serve.